Related Experiment Video
Updated: Jun 4, 2026
05:14
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Neurochemical imaging in schizophrenia
Nina Urban1, Anissa Abi-Dargham
1Department of Psychiatry, New York State Psychiatric Institute, Columbia University, New York, NY 10032, USA. nu2118@columbia.edu
Current Topics in Behavioral Neurosciences
|February 12, 2011
Summary
Neuroimaging techniques like PET and SPECT advance the study of brain chemistry in schizophrenia. These methods help identify neurotransmitter abnormalities and guide the development of better antipsychotic treatments.
Area of Science:
- Neuroscience
- Psychiatry
- Medical Imaging
Background:
- Neurochemical brain imaging methods have advanced the study of the living brain.
- Positrent emission tomography (PET) and single photon emission computed tomography (SPECT) are key tools in psychiatric research.
- Radiotracer availability has enabled detailed investigation of neurotransmitter systems.
Purpose of the Study:
- To review neurochemical brain imaging studies in schizophrenia.
- To explore abnormalities in dopamine and serotonin transmission.
- To assess antipsychotic drug mechanisms and efficacy.
Main Methods:
- Utilizing positron emission tomography (PET) and single photon emission computed tomography (SPECT).
- Employing radiotracers for neurotransmitter synthesis, transporters, and receptors.
- Comparing neurochemical indices in patients with schizophrenia and healthy controls.
Main Results:
- Identified abnormalities in dopamine and serotonin transmission in schizophrenia patients.
- Demonstrated the utility of imaging for characterizing antipsychotic drug target occupancy.
- Highlighted the potential for developing new imaging tools for GABA and glutamate systems.
Conclusions:
- Neurochemical brain imaging is crucial for understanding schizophrenia pathophysiology.
- These methods aid in evaluating antipsychotic drug action and optimizing treatments.
- Advancements in imaging tools promise improved disease detection and therapeutic strategies.
Related Concept Videos
01:14Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
01:29Biological Causes of Schizophrenia
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.